AllogeneiC Expanded Human MSC Therapy in Patients Recovering From COVID-19 Acute Respiratory Distress Trial

Stopped With available funding it was necessary for Sponsor to prioritize other studies. No study participants were consented or enrolled and no study sites were activated.

Conditions

• ARDS, Human

Interventions

• BIOLOGICAL: intravenous delivery of allogeneic bone marrow-derived MSCs

Sponsor

BioCardia, Inc.